Latest News

EMA website on phone and computer Image credit: AdobeStock/Timon
EMA grants positive CHMP opinion for low-dose atropine SYD-101

April 3rd 2025

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary end point for slowing pediatric myopia progression.

Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
CRU 2025: Exploring minimally invasive glaucoma surgeries

April 3rd 2025

FDA issues complete response letter for reproxalap - Image credit: Adobe Stock / ©FunnyLemon
FDA issues Complete Response Letter to Aldeyra Therapeutics for resubmitted New Drug Application of reproxalap

April 3rd 2025

Graphic of eye drop Image credit: AdobeStock/Wimon
Advancing presbyopia treatment through optimized design

April 3rd 2025

Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Emerging opportunities in inherited retinal diseases

April 2nd 2025

Latest Videos

Latest News

© 2025 MJH Life Sciences

All rights reserved.